24th April 2013 – Spire Cambridge Lea Hospital welcomes the reported findings of The NHS Medical Director, Professor Sir Bruce Keogh’s review into the UK’s cosmetic surgery industry. The review has assessed the current rules in England, investigating products, practitioners, insurance, patient information and consent, advertising and marketing of cosmetic interventions.
Believed to be worth £2.3 billion in 2010 and estimated to rise to £3.6 billion by 2015, the sector is growing at an incredible rate as people become increasingly accepting of the use of surgical and non-surgical procedures. Thousands of patients are treated each year and to date the non-surgical industry has been almost entirely unregulated.
Spire Healthcare is the second largest private hospital group in the UK and has witnessed a 10% increase in cosmetic surgery patients from 2011 to 2012.
Spire Healthcare’s Group Medical Director, Dr JJ de Gorter says, “A review of the cosmetic surgery industry is long overdue. I especially welcome the recommendation to establish a national implant register, as well as ensuring all those providing cosmetic interventions are properly registered to do so.”
Dr de Gorter also says that “All cosmetic surgeons working at Spire are on the GMC specialist register and hold appropriate indemnity cover. We are pleased the Keogh Review has put a spotlight on the cosmetic surgery industry and I believe these recommendations will prioritise patient safety and ensure individuals are able to access the best possible treatments with confidence.”
 Department of Health, Review of the Regulation of Cosmetic Interventions, P5